Skip to main content
Ruth Ruprecht, MD, Oncology, Boston, MA

Ruth Margrit Ruprecht MD


Professor of Medicine, Dana-Farber Cancer Institute

Join to View Full Profile
  • 44 Binney StDana-Farber Cancer Institute, Jfb 809Boston, MA 02115

  • Phone+1 617-632-3719

  • Fax+1 617-632-3112

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Ruth Ruprecht, MD is an oncologist in Boston, Massachusetts. She is a Professor of Medicine at Dana-Farber Cancer Institute.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1982 - 1983
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1980 - 1982
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1977 - 1980
  • University of Miami Leonard M. Miller School of Medicine
    University of Miami Leonard M. Miller School of MedicineClass of 1977

Publications & Presentations

PubMed

Press Mentions

  • Adjuvanted HIV-1 Vaccine Promotes Antibody-Dependent Phagocytic Responses and Protects Against Heterologous SHIV Challenge
    Adjuvanted HIV-1 Vaccine Promotes Antibody-Dependent Phagocytic Responses and Protects Against Heterologous SHIV ChallengeSeptember 3rd, 2020
  • Mymetics Receives Funding from NIH for Novel HIV Vaccine Study
    Mymetics Receives Funding from NIH for Novel HIV Vaccine StudyApril 29th, 2019
  • Evidence for Persistence of the SHIV Reservoir Early After MHC Haploidentical Hematopoietic Stem Cell Transplantation
    Evidence for Persistence of the SHIV Reservoir Early After MHC Haploidentical Hematopoietic Stem Cell TransplantationOctober 25th, 2018
  • Join now to see all